Category:Liande LI of Dallas TX (US)

Liande LI of Dallas TX (US)

Executive Summary

Liande LI of Dallas TX (US) is an inventor who has filed 2 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (2 patents), Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca (2 patents), Drugs for disorders of the nervous system (2 patents), and they have worked with companies such as The Board of Regents of The University of Texas System (2 patents). Their most frequent collaborators include (2 collaborations).

Patent Filing Activity

File:Liande LI of Dallas TX (US) Monthly Patent Applications.png

Technology Areas

File:Liande LI of Dallas TX (US) Top Technology Areas.png

List of Technology Areas

C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 2 patents
A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 2 patents
A61P25/00 (Drugs for disorders of the nervous system): 2 patents
C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
C12N2310/315 (of the backbone): 2 patents
C12N2310/3231 (modified ring structure): 2 patents